Gujarat Terce Laboratories Ltd

Gujarat-Terce-Laboratories-Ltd06 Dec 2024
Pharmaceuticals
₹
+1.51 (+1.99%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
BUY
SELL
To Invest in Gujarat Terce Laboratories Ltd
Gujarat Terce Laboratories Ltd
Pharmaceuticals
Gujarat-Terce-Laboratories-Ltd06 Dec 2024
₹
+1.51 (+1.99%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Gujarat Terce Laboratories Ltd - Share Price & Details

Traded Volume
₹
Market Cap(Cr)
Avg Traded Price
1 Year return
199.34%
Upper Circuit
Lower Circuit
P/E TTM
21.91
P/B Ratio
6.48
Traded Value(Cr)
0.00
EPS TTM
3.53
Book value
Dividend
0.00%

Invest in Gujarat Terce Laboratories Ltd at ZERO Brokerage for 30 days

Price Performance

1.78 %
1 Wk
-9.73 %
1 M
23.90 %
3 M
199.34 %
1 Y
170.93 %
YTD

Traded Volume Movement

Technical Details

Support 3
0
Support 2
0
Support 1
0
Pivot Point :
0
Resistance 1
0
Resistance 2
0
Resistance 3
0

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Gujarat Terce Laboratories Ltd
₹77.35(+1.51/1.99%)
77.35+1.5157.39199.3421.916.48
Ambalal Sarabhai Enterprises Ltd
₹58.37(+0.38/0.66%)
58.37+0.38447.3143.0650.769.93
Astrazeneca Pharma India Ltd
₹6,632.55(+2.00/0.03%)
6,632.55+2.0016,581.3837.91128.8124.41
Abbott India Ltd
₹29,053.50(+29.75/0.10%)
29,053.50+29.7561,738.6925.9148.0617.53
Amrutanjan Health Care Ltd
₹722.80(-15.20/-2.06%)
722.80-15.202,089.6621.2343.977.02
Bliss GVS Pharma Ltd
₹157.90(-2.90/-1.80%)
157.90-2.901,663.1918.2820.591.62

About Gujarat Terce Laboratories Ltd

Gujarat Terce Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 57.39 crores. It has reported a sales of Rs. 13.3 crores and a net profit of Rs. 1.48 crores for the quarter ended December 2018. The company management includes Natwarbhai P Prajapati, Amrutbhai P Prajapati,Chhayaben Ashwinbhai Shah,Viplav Suryakantbhai Khamar,Aalap Prajapati,Surendra Kumar Sharma,Navinchandra Patel,Natwarbhai P Prajapati (Gujarat Terce Laboratories Ltd) among others.
Chairman
Natwarbhai P Prajapati
Registered office
122/2 Ravi Estate,Bileshwarpura Chhatral,Gandhinagar,Gujarat,382729
FAX :
Background
Incorporation Year1985
Face Value₹10
Market Lot1

Latest News

89 smallcap stocks offer double-digit weekly returns

Despite a sluggish second-quarter economic growth rate, the markets maintained a positive bias throughout the week. Further, a positive turnaround from FIIs to India in expectation of a dovish monetary policy by RBI supported the sentiment. During the week, as many as 89 smallcap stocks have delivered double-digit weekly returns with eight of them offering gaining over 25%.
07 Dec 2024 | 10:48 AM

CEAT to buy Camso brand from France\'s Michelin for $225 mn

India's CEAT said on Friday it would buy French tyremaker Michelin's Camso brand for $225 million, as it looks to expand into higher-margin tyres at a time when elevated rubber prices have eaten into its profits. Camso, a Canadian brand that Michelin acquired in 2018 for $1.45 billion, makes tyres that are fitted into heavy-duty vehicles such as tractors, harvesters and bulldozers.
07 Dec 2024 | 10:47 AM

Asian shares slip on South Korea risk, dollar on guard ahead of payroll

Most Asian shares fell on Friday as political ructions in South Korea weighed on sentiment, while dollar bulls waited anxiously to see if U.S. payrolls challenged or cemented expectations of a rate cut this month. Chinese shares, however, climbed to three-week highs as investors scooped up technology shares ahead of a top-level policy meeting next week that will set the agenda.
07 Dec 2024 | 10:45 AM

Suven Pharmaceuticals acquires controlling stake in US-based NJ Bio

Suven Pharmaceuticals Limited has acquired a 56% controlling stake in NJ Bio Inc, a US-based Contract Research and Development Manufacturing Organisation (CRDMO) specialising in antibody-drug conjugates (ADC) and other emerging modalities. The investment, valued at ₹535 crore, strengthens Suven’s position as a technology-driven CDMO and marks a significant expansion of its footprint.
07 Dec 2024 | 10:44 AM

Buy or sell: Sumeet Bagadia recommends three stocks to buy on Mon— Dec 09

Sumeet Bagadia of Choice Broking believes the overall Indian stock market bias is positive, as the Nifty 50 index has broken above the 24,550 to 24,600 mark. Sumeet Bagadia's buy or sell stocks:
📌Tata Motors: Buy at ₹816.80, target ₹901, stop loss ₹780.
📌Axis Bank: Buy at ₹1184.55, target ₹1300, stop loss ₹1130.
📌BPCL: Buy at ₹@ 300.35, target ₹328, stop loss ₹287.
07 Dec 2024 | 10:07 AM
view more news

How to buy Gujarat Terce Laboratories Ltd shares on nse?

To buy Gujarat Terce Laboratories Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Gujarat Terce Laboratories Ltd share price today?

The Gujarat Terce Laboratories Ltd shares price on nse is Rs.77.35 today.

What is the market cap of Gujarat Terce Laboratories Ltd shares on BSE ?

The company has a market capitalization of Rs.57.39Cr

What is the PE & PB ratio of Gujarat Terce Laboratories Ltd shares ?

PE is 21.91 and PB is 6.48

What is the 52 Week High and Low of Gujarat Terce Laboratories Ltd shares?

Gujarat Terce Laboratories Ltd stock price high: Rs.94.9 Gujarat Terce Laboratories Ltd stock price low: Rs.26.25
BUY
SELL